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Motivation: Liver fibrosis is the result of an exacerbated scarring response after continuing damage of the tissue. (1). Hepatic 
stellate cells (HSCs) have been described as a key factor for this process. In the normal liver, HSCs remain quiescent and are 
only activated by an injury trigger (2). Previously, our group reported that GATA4 is a crucial factor for the maintenance of 
HSCs quiescence and the inhibition of fibrosis.  Therefore, unraveling the molecular pathways mediated by GATA4 could be 
useful for promoting fibrosis regression (3). In this project, we perform a lineage tracing assay in order to explore GATA4 
expression during regeneration after inducing fibrosis with tetrachloride (CCl4) in mice. In addition, we study the potential 
transcriptional repression of Hif2α by GATA4, a mechanism that could explain, at least in part, the role of GATA4 in the 
inhibition of liver fibrosis. 
Methods: CCl4 injections were used to induce liver fibrosis in a mouse model with constitutive GFP expression in HSCs. 
Livers were extracted and analyzed by immunofluorescence right at the end of the treatment and after 4 weeks of recovery. A 
conserved Hif2α intronic region, which contains two putative GATA sites were cloned into the pGL3 luciferase reporter 
plasmid. Transient transfections experiments were performed using pGl3-Hif2α plasmid and a plasmid for Gata4 constitutive 
expression to study the potential transcriptional repression of Hif2 by GATA4.  Dual-Luciferase ® Reporter Assay System 
(Promega) was used for luciferase measurement. 
Results: Preliminary results showed that reversion of activated HSCs to a quiescent state is accompanied by reactivation of 
GATA4 expression in mice recovering from CCl4 treatment. These results pointed to a crucial role of GATA4 for reversion of 
HSCs phenotype. On the other hand, 293T cells transfected with GATA4 expression plasmids showed reduced luciferase 
activity, which likely indicates a repression of Hif2α by GATA4 via the conserved GATA binding sites in the HIF2α enhancer 
region. 
Conclusions: There is growing evidence that GATA4 not only orchestrates the preservation of normal tissue organization, but 
also actively contributes to fibrosis regression. Moreover, our work proposes genetical regulation of Hif2α by GATA4 could be 
decisive for this process. 
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